A personalised mRNA vaccine shows lasting promise in pancreatic cancer, with early trial results suggesting it may help ...

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...

Moderna is expected to announce its fiscal first-quarter earnings next month, and analysts project a high single-digit ...

New findings reveal mRNA vaccines engage different dendritic cell subtypes to activate anti-tumor immunity, providing ...

WashU Medicine researchers have described how mRNA cancer vaccines engage the immune system, through an unconventional pathway involving two subsets of immune cells called dendritic cells.

As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

As drug candidates advance through clinical development, their value increases significantly due to rising probabilities of success and proximity to commercialization. The rise of fair-value ...

An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, ...

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...